Transitory tyrosinemia of newborn
ICD-10 P74.5 is a billable code used to indicate a diagnosis of transitory tyrosinemia of newborn.
Transitory tyrosinemia of the newborn is a metabolic disorder characterized by elevated levels of tyrosine in the blood due to a temporary deficiency in the enzyme fumarylacetoacetate hydrolase (FAH). This condition typically presents in the first few days of life and is often asymptomatic. It is important to differentiate transitory tyrosinemia from hereditary tyrosinemia, which is a more severe and chronic condition. The elevated tyrosine levels can lead to transient metabolic disturbances, but with appropriate dietary management, the condition usually resolves within a few weeks. Monitoring of tyrosine levels and clinical symptoms is essential during this period. The condition is often diagnosed through newborn screening programs that measure amino acid levels in the blood. Early identification and management are crucial to prevent potential complications, including liver dysfunction and neurological issues. Overall, transitory tyrosinemia is a self-limiting condition that requires careful monitoring and supportive care.
Detailed records of metabolic screening results, dietary interventions, and follow-up assessments.
Newborns presenting with elevated tyrosine levels during routine screening in the NICU.
Ensure accurate coding based on laboratory results and clinical assessments to avoid misdiagnosis.
Comprehensive documentation of growth and development assessments, dietary history, and metabolic evaluations.
Pediatric follow-up visits for newborns previously diagnosed with transitory tyrosinemia.
Consider the long-term monitoring of dietary intake and potential developmental impacts.
Used to confirm elevated tyrosine levels in newborns.
Document the reason for testing and results clearly.
Neonatologists should ensure that all metabolic screening results are included in the patient's chart.
Most newborns with transitory tyrosinemia have a good prognosis, as the condition is self-limiting and resolves with appropriate dietary management. Regular monitoring is essential to ensure normal development and prevent complications.
